Title : Implications of the Antiplatelet Therapy Gap Left With Discontinuation of Prasugrel in Canada.

Pub. Date : 2021 Jun

PMID : 34169260






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Methods: Five members of the Canadian Cardiovascular Society antiplatelet therapy 2018 guidelines committee undertook an independent, evidence-based review to outline patients for whom prasugrel should be the optimal P2Y12 agent and discuss alternative strategies to consider without prasugrel. Prasugrel Hydrochloride purinergic receptor P2Y12 Homo sapiens